MFDS — authorised 22 June 1998
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇰🇷 Priftin in South Korea
MFDS authorised Priftin on 22 June 1998
Marketing authorisation
Priftin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Priftin approved in South Korea?
Yes. MFDS authorised it on 22 June 1998.
Who is the marketing authorisation holder for Priftin in South Korea?
SANOFI AVENTIS US holds the South Korean marketing authorisation.